Accuracy of MRI Classification Algorithms in a Tertiary Memory Center Clinical Routine Cohort.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 8 3 2020
medline: 8 5 2021
entrez: 8 3 2020
Statut: ppublish

Résumé

Automated volumetry software (AVS) has recently become widely available to neuroradiologists. MRI volumetry with AVS may support the diagnosis of dementias by identifying regional atrophy. Moreover, automatic classifiers using machine learning techniques have recently emerged as promising approaches to assist diagnosis. However, the performance of both AVS and automatic classifiers have been evaluated mostly in the artificial setting of research datasets. Our aim was to evaluate the performance of two AVS and an automatic classifier in the clinical routine condition of a memory clinic. We studied 239 patients with cognitive troubles from a single memory center cohort. Using clinical routine T1-weighted MRI, we evaluated the classification performance of: 1) univariate volumetry using two AVS (volBrain and Neuroreader™); 2) Support Vector Machine (SVM) automatic classifier, using either the AVS volumes (SVM-AVS), or whole gray matter (SVM-WGM); 3) reading by two neuroradiologists. The performance measure was the balanced diagnostic accuracy. The reference standard was consensus diagnosis by three neurologists using clinical, biological (cerebrospinal fluid) and imaging data and following international criteria. Univariate AVS volumetry provided only moderate accuracies (46% to 71% with hippocampal volume). The accuracy improved when using SVM-AVS classifier (52% to 85%), becoming close to that of SVM-WGM (52 to 90%). Visual classification by neuroradiologists ranged between SVM-AVS and SVM-WGM. In the routine practice of a memory clinic, the use of volumetric measures provided by AVS yields only moderate accuracy. Automatic classifiers can improve accuracy and could be a useful tool to assist diagnosis.

Sections du résumé

BACKGROUND
Automated volumetry software (AVS) has recently become widely available to neuroradiologists. MRI volumetry with AVS may support the diagnosis of dementias by identifying regional atrophy. Moreover, automatic classifiers using machine learning techniques have recently emerged as promising approaches to assist diagnosis. However, the performance of both AVS and automatic classifiers have been evaluated mostly in the artificial setting of research datasets.
OBJECTIVE
Our aim was to evaluate the performance of two AVS and an automatic classifier in the clinical routine condition of a memory clinic.
METHODS
We studied 239 patients with cognitive troubles from a single memory center cohort. Using clinical routine T1-weighted MRI, we evaluated the classification performance of: 1) univariate volumetry using two AVS (volBrain and Neuroreader™); 2) Support Vector Machine (SVM) automatic classifier, using either the AVS volumes (SVM-AVS), or whole gray matter (SVM-WGM); 3) reading by two neuroradiologists. The performance measure was the balanced diagnostic accuracy. The reference standard was consensus diagnosis by three neurologists using clinical, biological (cerebrospinal fluid) and imaging data and following international criteria.
RESULTS
Univariate AVS volumetry provided only moderate accuracies (46% to 71% with hippocampal volume). The accuracy improved when using SVM-AVS classifier (52% to 85%), becoming close to that of SVM-WGM (52 to 90%). Visual classification by neuroradiologists ranged between SVM-AVS and SVM-WGM.
CONCLUSION
In the routine practice of a memory clinic, the use of volumetric measures provided by AVS yields only moderate accuracy. Automatic classifiers can improve accuracy and could be a useful tool to assist diagnosis.

Identifiants

pubmed: 32144978
pii: JAD190594
doi: 10.3233/JAD-190594
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1157-1166

Auteurs

Alexandre Morin (A)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Unité de Neuro-Psychiatrie Comportementale (UNPC), Paris, France.
Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Inria, Aramis-Project Team, Paris, France.

Jorge Samper-Gonzalez (J)

Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Inria, Aramis-Project Team, Paris, France.

Anne Bertrand (A)

Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Inria, Aramis-Project Team, Paris, France.
Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.

Sébastian Ströer (S)

Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.

Didier Dormont (D)

Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Inria, Aramis-Project Team, Paris, France.
Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.

Aline Mendes (A)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.

Pierrick Coupé (P)

Laboratoire Bordelais de Recherche en Informatique, Unit Mixte de Recherche CNRS (UMR 5800), PICTURA Research Group, Bordeaux, France.

Jamila Ahdidan (J)

Brainreader, Horsens, Denmark.

Marcel Lévy (M)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.

Dalila Samri (D)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.

Harald Hampel (H)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.
AXA Research Fund and UPMC Chair, Paris, France; Sorbonne Universities, Pierre et Marie Curie University, Paris, France.
ICM, ICM-INSERM 1127, FrontLab, Paris, France.

Bruno Dubois (B)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.
ICM, ICM-INSERM 1127, FrontLab, Paris, France.

Marc Teichmann (M)

Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.
ICM, ICM-INSERM 1127, FrontLab, Paris, France.

Stéphane Epelbaum (S)

Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Inria, Aramis-Project Team, Paris, France.
Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.

Olivier Colliot (O)

Sorbonne Universités, UPMC Univ Paris 06, Inserm, CNRS, ICM, Paris, France.
Inria, Aramis-Project Team, Paris, France.
Department of Neuroradiology, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France.
Department of Neurology, AP-HP, Hôpital de la Pitié-Salpêtrière, Institut de la Mémoire et de la Maladie d'Alzheimer (IM2A), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH